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Background: The pathogenesis of S. mansoni infection involves chronic inflammatory responses to parasite eggs
which can be associated with a characteristic periportal fibrosis (PPF) and the progression to severe hepatosplenic
disease. The effects of HIV-1 co-infection and the influence of CD4+ cell numbers on these clinical manifestations of
chronic S. mansoni are not known. To understand the effects of HIV-1 co-infection on these morbidities, we examined
S. mansoni ultrasound-detectable morbidities in relation to HIV-1 infection and CD4+ cell counts, and other factors in
fishing communities where the two infections are present.
Methods: Ultrasonographical examination was conducted during a cross-sectional study of 1,671 (aged 21–55 years)
individuals in North-Western Tanzania. Blood samples were obtained for HIV-1 screening and CD4+ cell quantification.
A single stool sample was examined for S. mansoni eggs using the Kato-Katz technique. A questionnaire was used to
collect socio-demographic-economic information.
Results: The prevalence of PPF (grade C-F) was 13.79% and 15.01% for the HIV-1 infected and non-infected individuals
(P = 0.72). Male gender (P< 0.001), age group 21–30 years (P< 0.028) and, residential time of 11–20 (P< 0.01) and ≥21 years
(P< 0.01) were associated with PPF in S. mansoni infected individuals. The height-adjusted measurements of the left liver
lobe were significantly larger in HIV-1/S. mansoni co-infected compared to S. mansoni only-infected individuals (t = −2.0702,
P< 0.039). Predictors of the height-adjusted measurements of the left liver lobe and spleen were age, male gender,
malaria infection, fishing occupation, village of residence and heavy intensity of S. mansoni infection. After accounting
for these factors, neither HIV-1 infection nor CD4+ cell counts predicted PPF, hepatosplenomegaly, measurements of
the liver or spleen. Height-adjusted ultrasound measurements of the left liver lobe did not correlate with the CD4+ cells
counts in co-infected individuals (r = −0.16, P = 0.084).
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Conclusion: S. mansoni-related PPF, liver and spleen enlargement are prevalent in the study population. The intensity
of S. mansoni infection was associated with the enlargement of liver, spleen and hepatosplenomegaly. The PPF grades
observed were similar in both HIV-1/S. mansoni co-infected and in those only infected with S. mansoni. There was no
evidence that HIV-1 infection or CD4+ cells counts were associated with these S. mansoni morbidities.
Keywords: S. mansoni, HIV-1, Co-infection, Periportal fibrosis, Liver and spleen sizes, TanzaniaBackground
Chronic S. mansoni infection can result in severe com-
plications and life-threatening hepatosplenic disease
[1,2]. The pathogenesis of the hepatosplenic form of the
disease is a result of the chronic immunological re-
sponses mediated by CD4+ T-lymphocytes directed
against S. mansoni eggs which are trapped within the
host body tissues including the liver [2,3]. Immuno-
logical responses against the eggs of the parasite trapped
in the liver are responsible for the development of peri-
ova granulomas, chronic exposure to which can be asso-
ciated with the development of fibrosis of the liver portal
tracts and associated morbidities [4,5]. Experimental
murine model studies suggest that granuloma formation
in S. mansoni infection is a CD4+ T-cells dependent
process [3,5-7]. The CD4+ cells are predominantly associ-
ated with the secretion of Th2 cytokines which contributes
to the development of hepatic fibrosis [8,9]. Evidence from
immunodeficient mice (nude, T-cell depleted and severe
combined immunodeficiency (SCID) mice characterized
by the absence of CD4+ T-lymphocytes and egg antibodies
response) [10-13], indicate that these animals suffer exac-
erbated severe hepatic parenchyma damage with reduced
granulomatous responses [10-13]. However, there are dif-
ferences between liver morbidity in S. mansoni infected
humans and mice; for example, infected mice do not de-
velop the PPF seen in human infections [8,14].
In human hosts, hepatosplenic disease is often accom-
panied by hepatic and splenic enlargement; progressive
periportal fibrosis (PPF) can lead to portal hypertension
and its sequelae [1-3,6,8,9], including ascites, liver sur-
face irregularities and portal-systemic venous shunts,
with the risk of oesophageal varices and haematemesis
[1-3,8,9]. Many of these manifestations of chronic mor-
bidity can be detected and measured by ultrasonography
and the degree of PPF severity is classified using a rec-
ommended World Health Organization grading scale,
agreed under the Niamey protocol [15-17]. Although im-
munological responses play a crucial role in the develop-
ment of hepatosplenic disease, epidemiological [18] and
demographic factors are also very important, including
the duration of residence in schistosomiasis endemic areas
[16,19,20], socio-economic factors such as the involve-
ment in fishing activities [16], as well as environmental
[18], genetical [21], parasitological factors [18,20-22] andco-infection with other tropical diseases such as malaria
[23,24]. Hepatomegaly or splenomegaly associated with
malaria infection is mainly a result of repeated inflamma-
tory responses characterized by hyperplasia of reticuloen-
dothelial and lymphoid tissues [25], which can be
exacerbated by chronic S. mansoni infection [23-25]. Any
study of the relationship between S. mansoni infection,
HIV-1 infection, hepatosplenic disease and its squelae, has
to take account of the effects of such factors.
The overall pathogenesis of HIV-1 infection is triggered
by the destruction or depletion of CD4+ T-lymphocytes
which consequently lead to the loss of immune compe-
tence [26,27] and an increase in the susceptibility of the
infected individuals to other infectious diseases [26]. It has
been hypothesized that the destructions of CD4+ T-
lymphocytes by HIV-1 infection may alter the sizes of the
left liver lobe and the patterns of hepatic fibrosis. This, in
turn, may increase the risk of hepatic parenchymal dam-
age due to an insufficient production of the Th2 cytokines
which are responsible for fibrogenesis [28,29]. In-vitro
studies have shown that T-cells from individuals co-
infected with HIV-1 and S. mansoni produced lower IL-4
and IL-10 and IFN-γ [28]. The inability to stimulate these
cells may lead to the development of a severe hepatic mor-
bidity. Furthermore, the observation that CD4+ T-cells are
required for S. mansoni eggs excretion in mice [30,31] and
that HIV-1 positive Kenyans infected with S. mansoni
have impaired parasite eggs excretion that correlates with
decreased CD4+ cell counts [32], suggest that the effects
of HIV-1 on CD4+ cells counts could lead to more para-
sites eggs being retained in the host body organs. Thus, in-
dividuals co-infected with HIV-1 and S. mansoni may
have altered ultrasonography detectable morbidities such
as severe hepatomegaly and splenomegaly compared to
those infected with S. mansoni alone. However, to date,
limited evidence is available [33].
To investigate the hypothesis that individuals co-
infected with HIV-1 and S. mansoni suffer severe ultra-
sound detectable morbidities as compared to individuals
infected with only S. mansoni infection. The present
study examined the prevalence and intensities of S. man-
soni infection and the related morbidities using ultrason-
ography in HIV-1 infected and un-infected population
(aged 21–55 years) to define the type of morbidities and
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sitological factors in development of these S. mansoni
morbidities and their association with left liver lobe and
spleen sizes, and hepatosplenomegaly. In addition, we
tested if the ultrasound measurements of the left liver lobe
are associated with the level of CD4+ cell counts in indi-
viduals co-infected with HIV-1 and S. mansoni infections.Methods
Study area, population and design
The study area, inclusion and exclusion criteria and sam-
pling procedures of the study participants are described in
Mazigo et al. [34,35]. In brief, the study included four vil-
lages of North-Western Tanzania, bordering the southern
shores of the Lake Victoria. All people who had lived in
the study villages for more than two years (referred to as
permanent residents) and aged 21 to 55 years were eligible
for enrolment. Individuals with a history of treatment for
schistosomiasis (praziquantel) in the past six months and
those who were on antiretroviral treatment (ART) were
excluded from the study at the baseline. A two-step sam-
pling procedure was used to select households and house-
hold members to participate in the study [34,35].Data collection
(i) Demographic information
Demographic information on sex, age, occupation, marital
status, village of residence, number of years lived in current
residence and level of education were collected with the
use of a questionnaire [34]. The detailed demographic
characteristics of the study participants are described in
Mazigo et al. [34]. In brief, complete parasitological data
and ultrasonographical data were obtained from 1,785 in-
dividuals aged 21–55 years, excluding n = 114 individuals
who were positive in an hepatitis C serological assay.
Therefore, a total of 1,671 individuals’ data were available
for the present analysis.(ii) Human Immunodeficiency Virus screening and CD4+
analysis
Human Immunodeficiency Virus-1 testing was conducted
according to the Tanzanian National HIV algorithms
which recommend the use of a rapid test qualitative im-
munoassay [36]; other procedures are described in detail
in Mazigo et al. [34,35]. The quantification of CD4+
cells was done using a FACSCalibur machine (Becton
Dickinson-BD Biosciences, San Jose, CA, USA) follow-
ing standard procedures [37]. Baseline results on HIV-1
infection are described in detail in Mazigo et al. [34,35].
Briefly, the prevalence of HIV-1 was 6.29%, (95% CI;
3.59-11.04).(iii) Parasitological screening for Schistosoma mansoni
A single stool sample was collected from all study par-
ticipants. Four Kato Katz thick smears were prepared
from different parts of the single stool sample using a
template of 41.7 mg (Vestergaard Frandsen, Lausanne,
Switzerland), following a standard protocol [38-40].
After 24 hours, the smears were independently exam-
ined for S. mansoni eggs by two experienced laboratory
technicians of the National Institute for Medical Re-
search (NIMR) laboratory. For quality assurance, a ran-
dom sample of 10% of the negative and positive Kato
Katz thick smears were re-examined by a third techni-
cian. At baseline, the overall prevalence of S. mansoni,
HIV-1 infections and their relationship with demo-
graphic characteristics of the study participants are de-
scribed in details in Mazigo et al. [34]. Briefly, the
overall prevalence of S. mansoni was 47.85%, (95% CI;
40.46-56.57). Only 40% (n = 50) of the HIV-1 infected in-
dividuals were co-infected with S. mansoni [34].
(iv) Parasitological screening for malaria
A finger prick blood sample was used to prepare thick
and thin blood films for malaria parasites diagnosis and
stained in 10% Giemsa (Sigma). The slides were exam-
ined under a microscope using objective X 100 under
oil-immersion [39]. Plasmodium falciparum parasite
density was determined, as described elsewhere [39]. At
baseline screening, the overall prevalence of malaria in-
fection was 8.02% (134/1,671) and the overall geomet-
rical mean parasite density was 450.41parasites/μL. The
prevalence of malaria did not vary by sex (χ2 = 0.0425,
P = 0.84) and age of the study participants (χ2 = 5.7853,
P = 0.12), though the age group 21–30 years (11.39%)
had a higher prevalence compared to other age groups.
In terms of occupation, those involved in farming had a
higher prevalence (10.8%), than those involved in other
economic activities but the difference was not significant
(P = 0.09).
(iv) Anthropometric measurements
Body height was measured by means of a locally con-
structed stadiometer using a tape measure fixed on a
wooden board, whereas body weight was measured using
electronic bathroom scales.
(v) Clinical and ultrasound examination
All study participants were clinically examined for
consistency of liver and spleen after submitting a single
stool sample. The procedures used for examination are
described in detail by Vennervald et al. [41]. An ultraso-
nographical examination of the study participant was
carried out by two experienced radiographer using a
portable ultrasound machine (Aloka, Tokyo). The modi-
fied Niamey Protocol was applied for classification of the
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ant were blinded with respect to the HIV-1 serostatus and
S. mansoni results. The liver texture patterns, peripheral
portal branches (PPBs), periportal fibrosis (PPF), thickness
of PPB walls, spleen size, splenic vein (SV) diameter and
ascites were assessed. Periportal fibrosis (PPF) was defined
according to WHO [15] and the degree of PPF was cate-
gorized as A, B, C, D, E and F [15]. Periportal fibrosis
grade A and B were classified as normal.
The liver length was measured along the para-sternal
line (PLL), whereas the spleen length was measured
along the mid clavicular line (MCL). The measurement
of portal vein diameter (PVD) was done at a midway be-
tween its entrance of the portal hepatica and its bifur-
cation inside the liver [15].
Treatment
All individuals found infected with S. mansoni at baseline
(aged 21–55 years), irrespective of their HIV-1 sero-status
or CD4+ cell count levels, were treated with a single dose
of praziquantel (40 mg/kg). Treatment was performed
under direct observation (DOT) of a qualified nurse.
Study participants received a cup of tea and some bread
before treatment to relieve the mild side effects of prazi-
quantel. In addition, after treatment, participants were re-
quested to remain at the treatment point for two hours to
observe and manage any possible adverse effects.
Ethical considerations
Ethical approval was obtained from the Higher Degrees
Research and Ethics Committee of the School of Public
Health, Makerere University (Institutional Review Board
(IRB) -00005856/2011) and from the Bugando University
College of Health Sciences and Allied Sciences-Institutional
Review Board, (BREC/001/32/2011). Ethical clearance was
granted by the National Ethical Review Committee,
National Institute for Medical Research, Tanzania and the
study was registered in the clinical trial network, Clinical
Trial (Number:- NCT-01541631). The study received
authorization from the regional and district administrative
authorities of Mwanza region and Ilemela district. Swahili
translated informed assent and consent forms were used
to obtain children (15- <18 years) and adult participants’
consent respectively. For illiterate individuals, a thumb
print was used to sign the assent and consent forms after
a clear description of the study objective. All HIV-1 infected
individuals found to have CD4+< 350 cells/μL were referred
to the Care and Treatment Clinic (CTC) for assessment of
their eligibility for antiretroviral therapy (ART).
Data management and analysis
The data were double entered using CSPro and the final
data set was stored in a MySQL database at the National
Institute of Medical Research (NIMR) Mwanza centre.Data were checked for consistency and errors were
cleaned. Data analysis was performed using stata version
12 (Stata Corp, College station, Texas, USA). The ultra-
sound measurements of the liver, spleen and portal vein
diameter of the study participants were compared be-
tween those who did or did not have detectable S. man-
soni infection using t-test. Similarly, the t-test was used
to compare organs sizes between individuals who were
mono-infected with S. mansoni and those who were co-
infected with S. mansoni and HIV-1.
To define the cut-off point between normal and en-
larged organs for ultrasound measurements, such as en-
larged spleen, enlargement of the left liver lobe and portal
vein dilatation, the Niamey protocol was used [15].
To assess the contributions of intensities of S. mansoni
and HIV-1 infections on the extent of the liver and
spleen enlargement, linear regression models were con-
structed for height-adjusted measurements of the left
liver lobe and the spleen. Explanatory variables included
in the models were sex, age, occupation, village of resi-
dences, malaria infection, HIV-1 serostatus and inten-
sities of S. mansoni. Bivariate and multivariable logistic
regression models were also constructed to identify fac-
tors associated with PPF and hepatosplenomegaly. At bi-
variate analysis, individuals factors were analyzed with
the outcome of interest and explanatory variable with P-
value <0.2 were considered for multivariable analysis.
Explanatory variables entered were the same for linear
regression. Unadjusted and adjusted Odd Ratio and their
95% confidence interval (95% CI) were generated and
used to measure the strength of association between
outcome and explanatory variables. The Spearman cor-
relation test was used to test any correlation between
height adjusted left liver lobe ultrasound measurements
and CD4+ counts in individuals co-infected with HIV-1
and S. mansoni. Values for P< 0.05 were considered
significant.
Results
(a) Prevalence of periportal fibrosis (PPF) and associated
factors
The overall prevalence PPF (grades C-F) was 14.78%
(247/1,671, 95% CI: 13.28-16.72). In relation to S. man-
soni infection, of the individuals detected with PPF,
52.23% (129/247) had detectable S. mansoni eggs in their
stool samples and 47.77% (118/247) had no detectable S.
mansoni eggs. In general, the prevalence of PPF did not
vary by S. mansoni infection status (χ2 = 2.6768, P = 0.10)
and categories of intensities of infection in terms of egg
count (epg) (χ2 = 6.1379, P = 0.11). The stratification of
PPF grades and infection with S. mansoni are shown
Table 1 and there was no significance difference between
individuals who were either infected or not with S. man-
soni infection (P = 0.39). Of the 247 individuals with PPF,
Table 1 Prevalence of peri-portal grades and hepatosplenomegaly in relation to Schistosoma mansoni infection status
Variables Schistosoma mansoni status ÷2 P-values
Negative (N = 831) Positive (N = 840)
Hepatosplenomegaly
Both liver + spleen not enlarged 305 291 4.5425 0.21
(36.70) (34.64)
Only spleen enlarged 78 91
(9.39) (10.83)
Only liver enlarged 327 313
(39.35) (37.26)
Both spleen and liver enlarged 121 145
(14.56) (17.26)
Peri portal fibrosis grades
Normal 713 710 4.1566 0.39
(85.80) (84.52)
Grade C 32 41
(3.85) (4.88)
Grade D 66 64
(7.94) (7.62)
Grade E 15 20
(1.81) (2.38)
Grade F 5 4
(0.60) (0.48)
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14.17% (35/247) E and 3.64% (9/247) were grade F. Of
the individuals infected with S. mansoni and having
PPF, 31.78% (n = 41/129) in grade C, 49.61% (n = 63/
129) in grade D, 12.02% (n = 20/129) in grade E and
3.10% (n = 4/129) in grade F had egg positives Kato Katz
slides.
In relation to other demographic factors, males indi-
viduals had a higher prevalence of PPF than females
(157/247, 20.08% versus 90/247, 10.31%, χ2 = 30.9943,
P< 0.001) and a higher prevalence of more severe fibrosis
(grade D, E, or F) (P< 0.001). PPF prevalence did not sig-
nificantly vary by age group (χ2 = 1.3521, P = 0.72), al-
though the age group 31–40 years (15.08%) and 41–50
years (16.94%) groups had the highest PPF prevalence.
Individuals involved in fishing activities had the highest
prevalence of PPF (25.30%, χ2 = 26.0954, P< O.001). The
prevalence of PPF varied significantly by villages of resi-
dence with Kayenze (17.02%) and Igalagala (19.65%) hav-
ing the highest prevalence (χ2 = 16.5998, P< 0.001) and
duration of residence (χ2 = 14.2821, P = 0.01), with those
reported living in the study for 11–20 years (19.32%)
and ≥ 21 years (18.16%) having the highest prevalence.
In relation to HIV-1 infection, 13.79% and 15.01% of
the HIV-1 infected and uninfected individuals had PPF
(χ2 = 0.1258, P = 0.72) respectively. Of these n = 4 hadgrade C, n = 8 had grade D and n = 4 had grade E-F. The
prevalence of PPF did not differ by HIV-1 serostatus,
(χ2 = 0.1258, P = 0.72).
To ascertain the importance of HIV-1 infection as pre-
dictor of PPF, a logistic regression model that included S.
mansoni infection or number of S. mansoni eggs per gram
of faeces, duration of residency, age, village of residence,
occupation, malaria infection and sex as explanatory fac-
tors was developed among S. mansoni infected individuals
with PPF as the outcome variable (Table 2). A bivariate
analysis, male gender (P< 0.004) and residential year of 11–
20 years (P< 0.035) were associated with PPF. At multivari-
able analysis, male gender (AOR = 2.27, 95% CI; 1.41 –
3.65, P< 0.001), age group 21–30 years (AOR = 2.45,95%
CI: 1.09 - 5.47, P< 0.028) and residential time, 11–20 years
(AOR = 3.52,95% CI; 1.38-8.93, P< 0.01) and ≥21 years
(AOR = 2.66,95% CI: 1.27-5.58, P< 0.01) (Table 2).(b) Comparison of the height adjusted mean deviations of
organs in relation to infection with S. mansoni
Table 3 shows the comparison of mean deviations of or-
gans in relation to S. mansoni infection. In general, the
height-adjusted ultrasound measurements of the left liver
lobe (t = 0.8851, P = 0.38), spleen (t = −0.5639, P = 0.57)
and portal vein diameter (t = −0.1710, P = 0.86) did not
Table 2 Factors associated with Periportal fibrosis among resident of fishing villages of North-western Tanzania
Variable cOR 95% CI P-value aOR 95% CI P-value
Sex
Female 1 1
Male 1.79 1.21 – 2.68 0.004 2.27 1.41 – 3.65 0.001**
Age (in years)
21 – 30 1.35 0.71 – 2.53 0.36 2.45 1.09 – 5.47 0.028**
31 – 40 1.32 0.68 – 2.54 0.40 1.42 0.62 – 3.26 0.40
41- 50 1.16 0.53 – 2.55 0.71 1.34 0.56 – 3.28 0.51
51 - 55 1 1
Occupation
SSB* 1 1
Farming 0.74 0.41 – 1.34 0.33 ———— ———— —————
Fishing 1.26 0.64 – 2.45 0.50 ———— ———— —————
Village of residence
Igombe 1 1
Sangabuye 0.52 0.26 – 1.03 0.06 0.39 0.18 – 0.85 0.018
Kayenze 1.17 0.71 – 1.94 0.53 1.05 0.59 – 1.85 0.19
Igalagala 1.44 0.79 – 2.62 0.23 1.74 0.74 – 4.06 0.19
Residential years
≥ 2 - 5 1 1
6 – 10 1.18 0.57 – 2.44 0.64 1.09 0.49 – 2.45 0.81
11 – 20 2.02 1.05 – 3.87 0.035 3.52 1.38 – 8.93 0.01**
≥ 21 1.42 0.79 – 2.57 0.24 2.66 1.27 – 5.58 0.01**
Malaria infection
No 1 1
Yes 0.57 0.26 – 1.24 0.16 0.72 0.32 – 1.61 0.43
HIV-1 infection
No 1
Yes 0.90 0.39 – 2.08 0.81 ——— ——— ———
Intensity of S. mansoni iinfection (epg)
1-100 1 1
101 – 399 0.91 0.55 – 1.49 0.72 0.84 0.47 – 1.46 0.53
≥400 1.38 0.89 – 2.13 0.14 1.11 0.66 – 1.86 0.68
SSB* = small scale business, cOR = Crude Odd Ratio, aOR = Adjusted Odd Ratio.
**significant P-values for factors associated with peri-portal fibrosis.
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not with S. mansoni infection.
(c) Comparison of the height-adjusted size of the of the
organs in relation to HIV-1 infection
Table 4 shows a comparison of the height-adjusted size
of the left liver lobe, spleen and portal vein diameter in re-
lation to HIV-1 infection. The height-adjusted ultrasound
measurements of the left liver lobe were significantly larger
in individuals co-infected with HIV-1 and S. mansoni com-
pared to S. mansoni only infected individuals (t = −2.0702,
P< 0.039). However, the height-adjusted ultrasoundmeasurements of the spleen (t = −1.3664, P = 0.17) and
portal vein diameter (t = 0.8072, P = 0.42) did not differ sig-
nificantly between individuals co-infected with HIV-1 and
S. mansoni infection compared to S. mansoni-only infected
individuals.
(d) Correlation between the height-adjusted ultrasound
measurements of the left liver lobe, spleen, portal vein
diameter and intensity of S. mansoni infection
The Spearman correlation test was used to determine
whether the size of the left liver lobe and spleen corre-
lated with the intensity of S. mansoni infection. For
Table 3 Comparison of the height adjusted mean deviations of organs stratified by infection with S. mansoni
Organomegaly Schistosoma mansoni status F-ratio P-values
Not Infected with S. mansoni (N = 831)
deviations from mean (95% CI)
Infected with S. mansoni (N = 840)
deviations from mean (95% CI)
Liver
Left liver lobe length 2.34 (2.22 – 2.47) 2.27 (2.14 – 2.39) 0.8851 0.38
Spleen
Spleen length 1.19 (1.06 – 1.31) 1.23 (1.11 – 1.35) −0.5639 0.57
Portal vein Diameter
Portal vein length 1.03 (0.96 – 1.10) 1.04 (0.97 – 1.11) −0.1710 0.86
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tion remained significantly correlated with height-adjusted
length of the left liver lobe (r = 0.073, P< 0.0244) and height-
adjusted length of the spleen (r = 0.089, P< 0.006). However,
the height-adjusted portal vein (r = 0.004, P = 0.89) and
portal branch wall thickness (r = 0.0656, P = 0.73) mea-
surements did not correlate with S. mansoni intensity of
infection.
(e) Correlation between the height-adjusted ultrasound
measurements of the left liver lobe and CD4+ cell counts
For individuals who were co-infected with HIV-1 and S.
mansoni, the height-adjusted ultrasound measurements of
the left liver lobe did not correlate with CD4+ T-cell counts
among the co-infected individuals (r = −0.16, P = 0.084)
Figure 1.
(f) Predictors of left liver lobe hepatomegaly,
splenomegaly and hepatosplenomegaly
To assess the contribution of HIV-1, S. mansoni and
other explanatory variables on the extent of left liver
lobe and spleen, linear regression models were devel-
oped with height adjusted ultrasound measurements of
the left liver lobe and spleen as continuous outcome var-
iables for individuals who had detectable S. mansoni
eggs in faecal samples. The ultrasound adjusted left liver
lobe measurements were significantly associated with
the age of the study participants (P< 0.038), malariaTable 4 Comparison of the height-adjusted size of the left liv
with HIV-1 serostatus
Organomegaly HIV-1 serostatus
HIV-1 negative infected with S. mansoni
(N = 790) deviations from mean (95% CI)
Liver
Left liver lobe length 2.23 (2.11 – 2.36)
Spleen
Spleen length 1.21 (1.08 – 1.34)
Portal vein Diameter
Portal vein length 1.04 (0.97 – 1.12)
**significant P-values.infection (P< 0.038) and intensities of S. mansoni infection
(P< 0.01). HIV-1 infection was not a significant predictor
of left liver lobe ultrasound measurements (P = 0.069)
(Table 5).
Table 6 shows the predictors of height-adjusted ultra-
sound measurements of the spleen. Spleen measurements
were significantly associated with sex of the participants
(being male, P< 0.002), fishing occupation (P< 0.005), vil-
lage of residence (living in Kayenze village, P< 0.039 and
Igalagala village, P< 0.005), being infected with malaria
parasite (P< 0.018) and HIV-1 infection (P< 0.05).
The prevalence of organomegaly (hepatomegaly, spleno-
megaly and hepatosplenomegaly) in relation to HIV-1 and
S. mansoni infections is shown in Table 1. Overall, based
on the Niamey protocol categories, 13.73% (167/1,216)
had an enlarged spleen, 59.70% (726/1,216) had hepato-
megaly and 26.56% (323/1.256) had hepatosplenomegaly.
There was no significant difference in the prevalence of
these morbidities in individuals who were only infected
with S. mansoni and those who were co-infected with
HIV-1/S. mansoni (Fisher exact, P = 0.40). Similarly, no
significant difference was observed in relation to these
morbidities in individuals with detectable S. mansoni eggs
and those with no detectable eggs in their stool samples
(P = 0.07). To ascertain the importance of demographic
factors, HIV-1, malaria infection and intensities of S. man-
soni infections, on the risk of developing hepatosplenome-
galy among individuals infected with S. mansoni, a logisticer, spleen and portal vein diameter in relation to infection
F-ratio P-values
HIV-1 positive co-infected with S. mansoni
(N = 50) deviations from mean (95% CI)
2.79 (2.23 – 3.37) −2.0702 0.039**
1.57 (1.14 – 2.00) −1.3664 0.17





3 4 5 6 7
CD4+ cell counts (x 100cells/microLitre)
Fitted values Schistosoma mansoni GMepg(log +1)
Figure 1 Scatter plot of correlation of left liver lobe ultrasound measurements and CD4+ counts in individuals co-infected with HIV-1 and S. mansoni.
Ultrasound measurements were adjusted for height of individuals. The no correlation was observed between left liver lobe ultrasound measurements
and CD4+ counts (r = −0.16, P = 0.084).
Table 5 Predictors of left liver lobe size among residents
of fishing villages of North-Western Tanzania infected
with S. mansoni
Variable â SE 95% CI P-values
Sex −0.1735 0.1390 −0.446 – 0.0994 0.21
Age 0.0100 0.0048 0.00058 – 0.0195 0.038**
Occupation
SSB* 1
Peasants 0.1357 0.2147 −0.29 – 0.55 0.53
Fishing 0.1474 0.2649 −0.37 – 0.67 0.58
Villages of residence
Igombe 1
Sangabuye 0.2185 0.2025 −0.17 – 0.62 0.28
Kayenze 0.1104 0.1762 −0.24 – 0.46 0.53
Igalagala 0.3354 0.2873 −0.23 – 0.89 0.24
Malaria infection
No 1
Yes 0.4142 0.1989 0.023 – 0.80 0.038**
HIV-1 serostatus
Negative 1
Positive 0.5258 0.2889 −0.04 – 1.093 0.069
Schistosoma mansoni intensity (log epg)
S. mansoni intensities 0.1076 0.0416 0.026 – 0.189 0.01**
*SME – small scale business ** significant factors associated with left liver
lobe hepatomegaly.
R2 = 0.0264, Adjusted R2 = 0.0140 F = 2.14 and P< 0.02.
Linear regression model was constructed for height adjusted ultrasound
measurements of the left liver lobe(organ size as continuous variable- i.e.
deviations from mean).
Table 6 Predictors of spleen size among residents of
fishing villages of North-Western Tanzania infected with
S. mansoni
Variable â SE 95% CI P-values
Sex 0.3968 0.1273 0.14 – 0.65 0.002**
Age −0.0005 0.0044 −0.009 – 0.0081 0.91
Occupation
SSB* 1
Peasants 0.2445 0.1966 −0.1413 – 0.63 0.21
Fishing 0.4726 0.2426 −0.003 – 0.94 0.05**
Villages of residence
Igombe 1
Sangabuye 0.3164 0.1854 −0.047 – 0.68 0.088
Kayenze 0.3333 0.1613 0.016 – 0.65 0.039**
Igalagala 0.7331 0.2630 0.22 – 1.24 0.005**
Malaria infection
No 1
Yes 0.43 0.1821 0.073 – 0.788 0.018**
HIV-1 serostatus
Negative 1
Positive 0.5186 0.2645 −0.00076 – 1.037 0.05**
Schistosoma mansoni intensity (log epg)
S. mansoni intensities 0.068 0.0381 −0.0061 – 0.1435 0.072
*SSB – small scale business ** significant factors associated with splenomegaly.
R2 = 0.0564, Adjusted R2 = 0.0445 F = 4.72 and P< 0.0001.
Linear regression model was constructed for height adjusted ultrasound
measurements of the spleen (organ size as continuous variable-i.e. deviations
from mean).
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as the outcome variable (Table 7). At bivariate analysis, var-
iables significantly associated with hepatosplenomegaly
were village of residence and heavy intensity of S. mansoni
infection. At multivariable analysis, village of residence (liv-
ing at Sangabuye village, AOR = 2.21, 95% CI; 1.15– 4.25,
P< 0.017, Kayenze village, AOR= 2.06, 95% CI; 1.15-3.71,
P< 0.016) and Igalagala, AOR= 2.62, 95% CI; 1.15-5.93,
P< 0.021) and being heavily infected with S. mansoni infec-
tion (AOR= 1.54, 95% CI; 1.01- 2.39, P< 0.047) remained
independently associated with hepatosplenomegaly. HIV-1
infection was not a predictor (Table 7).
Discussion
In the present study population, we observed a consider-
ably lower prevalence of PPF (grade C-F) than what pre-
viously reported in studies from the same geographicalTable 7 Predictors of hepatosplenomegaly among residents o
S. mansoni infection
Variable COR 95% CI P-v
Sex
Female 1
Male 1.24 0.89 – 1.71 0.19
Age (in years)
21 – 30 0.81 0.45 – 1.46 0.48
31 – 40 0.81 0.44 – 1.48 0.49
41 – 50 0.91 0.44 – 1.88 0.79
51 - 60 1
Occupation
SSB* 1
Peasants 1.14 0.66 – 1.95 0.64
Fishing 1.51 0.80 – 2.83 0.20
Village of residence
Igombe 1
Sangabuye 1.98 1.15 – 3.43 0.01
Kayenze 1.84 1.11 – 3.03 0.01
Igalagala 2.36 1.33 – 4.17 0.00
Malaria infection
No 1
Yes 1.31 0.78 – 2.16 0.29
HIV-1 serostatus
Negative 1
Positive 1.60 0.83 – 3.09 0.16
Intensity of Schistosoma mansoni infection (epg)
1-100 epg 1
101 – 399 epg 1.15 0.75 – 1.76 0.53
≥400 epg 1.59 1.09 – 2.32 0.01
cOR = Crude Odd Ratio, aOR = Adjusted Odd Ratio.
**Significant P-values for factors associated with hepatosplenomegaly.setting (16.7%) and on the islands of Ukerewe (36% and
41.5%), North-Western Tanzania [42,43]. Similarly, in
comparison to other studies that used the Niamey proto-
col in sub-Saharan Africa, our prevalence of PPF was
low [18,19,44]. The observed variations in PPF between
various epidemiological settings can partly be explained
by differences in prevalence and intensities of S. mansoni
infection, the focal nature of transmission of the disease
[18,19,45-48], the genetic background of the endemic
communities and the length of time individuals have
been exposed to S. mansoni infection [21,44]. In
addition, co-infection with other tropical diseases such
as malaria [46], differences in parasites strains [49] and
immune responses [5] may contribute to the observed
variation in prevalence of PPF between communities.
It has been hypothesized that HIV-1 infection, patho-
genesis of which leads to a decreased level of CD4+ cellf fishing villages of North-Western Tanzania infected with
alues AOR 95%CI P-values
1
1.18 0.79 – 1.76 0.42
0.65 0.34 – 1.22 0.18
0.59 0.31 – 1.13 0.11
0.66 0.30 – 1.45 0.30
1
1
0.78 0.42 – 1.45 0.43
1.12 0.53 – 2.35 0.77
1
4 2.21 1.15 – 4.25 0.017**
7 2.06 1.15 – 3.71 0.016**
3 2.62 1.15 – 5.93 0.021**
1
1.34 0.78 – 2.28 0.29
1 1
1.63 0.65 – 1.72 0.82
1
1.06 0.65 – 1.72 0.82
5 1.54 1.01 – 2.39 0.047**
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bidities in HIV-1/S. mansoni infected individuals. Thus,
individuals co-infected with HIV-1/S. mansoni may present
with severe PPF grades. We have observed HIV-1 positive
individuals either with S. mansoni detectable egg in their
stool samples or not presenting with PPF. There was no
significant difference in prevalence of PPF between individ-
uals co-infected with HIV/S. mansoni and those who were
not infected with HIV-1 infection. Consistent findings were
reported among Kenyan patients co-infected with HIV-1/S.
mansoni [33]. HIV-1 infected individuals were not at a
higher risk of either experiencing severe or different PPF
grades associated with S. mansoni infection than HIV-1
non-infected individuals [33].
On the other hand, the explanatory factors observed
to be associated with PPF in the present study have also
been reported by similar studies in S. mansoni endemic
areas [18,19,21,43]. The gender related association with
PPF mainly reflect either gender-specific factors [18,21]
or differences in the length of exposure between sexes to
risk areas [21]. The development of PPF and its associ-
ated morbidities detected by ultrasound, can take years
of infection to become manifest. Increased duration of
residence in high risk areas, which defines the length of
exposure to potential risk areas characterized by an in-
tense transmission and the interactions of immune sys-
tem and S. mansoni eggs trapped in the host body,
remains an important factor for the development of
these morbidities [5,8,19]. Our present work and those
of other authors [19,21], we observed that the risk of
periportal fibrosis was higher after an individual have
been exposed for more than a decade.
HIV-1 infection or its immunodeficiency, as measured
in term of CD4+ cell counts, was not associated with
PPF. It is worth to note that the presence of relatively
non-severely CD4+ depleted individuals observed in the
present study could have contributed to the lack of asso-
ciation between PPF and HIV-1 or CD4+ count levels.
However, in the absence of HIV-1 infection, decreased
CD4+ cell counts with increased PPF grades score have
been observed, in individuals who had PPF grades D/E
and had lower median CD4+ cell counts [33]. Retesting
this hypothesis with a larger study population would be
needed to allow a definitive conclusion.
In the present study, we also assessed if HIV-1 infec-
tion had an influence on the height adjusted size of the
left liver lobe, spleen and portal vein diameter among in-
dividuals infected with S. mansoni. Our findings indicate
that the height-adjusted size of the left liver lobe was sig-
nificantly enlarged in individuals co-infected with HIV-1
and S. mansoni compared to individuals infected with S.
mansoni only. The chronic immune activation associated
with the pathogenesis of HIV-1 infection, which also tar-
gets other immune cells such as macrophages, doescontribute to the increase in the size of the left liver lobe
[51,52]. Also, evidence from immunological studies has
shown that the left liver lobe predominantly increases in
size in S. mansoni infection [5,9], and epidemiological
studies have shown the relationship between the in-
crease in size of the left liver lobe and the intensity of S.
mansoni infection [16,18,20,42,53,54]. Perhaps, these ob-
servations suggest that, in co-infected individuals, HIV-1
and S. mansoni may have additive effects on the size of
the left liver lobe, with S. mansoni infection influencing
the size of the organ in intensity-dependent manner.
This observation has also been reported in individuals
co-infected with P. falciparum and S. mansoni, in which
P. falciparum was associated with hepatosplenomegaly
exacerbated by the intensity of S. mansoni infection in
dependent manner [23,24]. The increase in size of the left
liver lobe in HIV-1 infected individuals co-infected with
other tropical diseases, pathogenesis of which involve the
liver has been also reported for HIV-1/Hepatitis-C co-
infection [55]. Our findings on the contribution of S. man-
soni and HIV-1 infections on the size of the liver present
an important clinical feature for evaluating and managing
hepatomegaly in HIV-1 infected individuals living in S.
mansoni endemic countries. S. mansoni should be consid-
ered as one of the differential diagnosis in causing hepato-
megaly in HIV-1 infected individuals.
`In the present study population, no correlation was ob-
served between the left liver lobe size and CD4+ T- cell
counts among individuals co-infected with S. mansoni and
HIV-1 infection. Evidence from S. mansoni animal model
studies, S. mansoni infected immunodeficient mice have
reduced ability to form protective granulomas and suffer
severe hepatic parenchymal cell damage caused by hepa-
totoxins secreted from parasite eggs [3,56]. In Western
Kenya, the level of glutamic oxaloacetic transminase
(GOT) enzymes, markers of liver parenchyma damage,
did not correlate significantly with CD4+ T-cell counts
[33], suggesting the reduced level CD4+ cells observed
were still protective against S. mansoni egg hepatotoxins,
perhaps by continuing to support the production of anti-
egg hepatotoxins. It is worth noting that immuno-
suppressed mice studies result a much greater depletion
of CD4+ T-cells than is seen in the individuals included in
this or previous human studies.
On the other hand, S. mansoni egg counts correlated
significantly with the height-adjusted ultrasound measure-
ments of the left liver lobe and the spleen. In addition, lin-
ear regression analysis revealed a number of factors which
were either associated height-adjusted ultrasound mea-
surements of the left liver lobe or the spleen. These ex-
planatory factors observed in the present study have also
been described in previous studies to interact in causing S.
mansoni-related left liver lobe hepatomegaly, splenomeg-
aly and hepatosplenomegaly in different age groups
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organomegaly reflects the variation in transmission inten-
sity of S. mansoni between geographical areas, age and sex
differences in the exposure to S. mansoni risk areas [53].
In high endemic S. mansoni transmission areas, children
are often infected within the first two or three of life males
are suffer high infection intensities than females and inten-
sity of infection increases with age [5]. In these areas, the
majority of adults with an increased risk of exposure to in-
fection, such as fishermen, can have significantly enlarged
left liver lobe, spleen or both. However, enlarged left liver
lobe and spleen, can also found in some areas to be highly
prevalent in younger age groups, [5,53]. In these younger
groups, left liver lobe size has been shown to correlate with
high intensities of S. mansoni infection [16,20,53,57]. Simi-
larly, the contribution of P. falciparum infection to the left
liver lobe and spleen enlargement, and hepatosplenome-
galy has been repeatedly reported in endemic areas [23,24].
Where co-infection of S. mansoni and P. falciparum oc-
curs, these infections have synergistic effects in causing the
enlargement of the left liver lobe [23,24].
Our study was subject to some limitations. The small
number of S. mansoni/HIV-1 co-infected individuals
could have affected the power of the study to detect par-
ticular changes in those individuals. Thus, some caution
must be taken when the interpretation of these findings
is carried out. However, despite this limitation, this was
a community-based study which recruited a large num-
ber of participants living in potential risk areas for S.
mansoni and HIV-1 infections.
Conclusion
Schistosoma mansoni-related morbidities such as PPF,
enlarged left liver lobe, enlarged spleen and hepatosple-
nomegaly are present in the study population and are as-
sociated with various risk factors, including the intensity
of S. mansoni infection. HIV-1 infected individuals, ei-
ther with detectable S. mansoni eggs in their stool sam-
ples or not, had PPF, enlarged left liver lobe, enlarged
spleen and hepatosplenomegaly. The PPF grades ob-
served in HIV-1/S. mansoni co-infected individuals were
similar to those individuals infected only with S. man-
soni. However, HIV-1 infection or CD4+ cell counts were
not associated with PPF grades.
Our results indicate that the sizes of the left liver lobe,
spleen and portal vein diameter did not vary between in-
dividuals infected or not infected with S. mansoni infec-
tion, thus indicating that current S. mansoni infection
was not the only underlying cause of enlarged liver and
spleen in the present study population. Individuals co-
infected with S. mansoni and HIV-1 infection had a sig-
nificantly larger size of the left liver lobe as compared to
individuals with S. mansoni-only infection, thus indicat-
ing that, the two infections could interact in causing theenlargement of the left liver lobe. However, on a regression
model, HIV-1 infection was not a predictor of the enlarge-
ment of the left liver lobe and immunodeficiencies effects
of HIV-1 infection, as measured by CD4+ T-cell levels in
co-infected individuals, did not correlate positively with
the height-adjusted ultrasound measurements of the left
liver lobe. Lastly, the implication of our observations is that
individuals co-infected with HIV-1/S. mansoni, although
affected by a S. mansoni related organomegaly similar to S.
mansoni only-infected individuals, could be suffering se-
vere enlargement of these organs. To reduce the burden of
other infections and their associated morbidities, they
should be either routinely screened and treated when visit-
ing care and treatment clinics (CTC) or other public health
measures should be included in the CTC package to re-
duce their exposure to S. mansoni infection.
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